Home › Progenics Pharmaceuticals Relaunches Pivotal Trial of AZEDRA(TM) in Pheochromocytoma
 

Keywords :   


Progenics Pharmaceuticals Relaunches Pivotal Trial of AZEDRA(TM) in Pheochromocytoma

2015-01-23 18:05:55| Biotech - Topix.net

Progenics Pharmaceuticals, Inc., announced today that it has dosed the first subject in the resumed pivotal Phase 2 clinical study of Azedra in patients with malignant pheochromocytoma and paraganglioma. The trial is being conducted under a Special Protocol Assessment with the U.S. Food and Drug Administration .

Tags: trial pharmaceuticals pivotal relaunches

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
24.11 Beautiful World CD
24.11VIII
24.11PLUS MADHOUSE( ) 2
24.11KATO 10-1537 415
24.11125f-slim
24.11
24.11olend ona soft bag
24.1110ONKYO
More »